述评｜刘平：肝胆胰疾病中西医结合治疗现状与展望

参考文献

［1］ZHANG L, SCHUPPAN D. Traditional Chinese Medicine (TCM) for fibrotic liver disease: Hope and hype［T］. J Hepatol, 2014, 61(1): 166-168.

［2］DONG S, CHEN QL, SU SB. Curative effects of Fuzheng Huayu on liver fibrosis and cirrhosis: A Meta-analysis［J］. Evid Based Complement Alternat Med, 2015, 2015: 125659.  

［3］CHEN J, HU Y, CHEN L, et al. The effect and mechanisms of Fuzheng Huayu formula against chronic liver diseases［J］. Biomed Pharmacother, 2019, 114: 108846. 

［4］GU J, ZHANG Q, XUE D, et al. A randomized controlled study of fuzheng huayu capsule for prevention of esophageal variceal bleeding in patients with liver cirrhosis［J］. Evid Based Complement Alternat Med, 2013, 2013: 534960.

［5］CHEN Y, YANG YP.  The role of traditional Chinese medicine in blocking and reversing hepatic fibrosis: Current status, hope, and challenge［J］. J Clin Hepatol, 2018, 34(4): 689-693. (in Chinese) 

陈艳， 杨永平. 中医药阻断逆转肝纤维化的近况、进展与挑战［J］. 临床肝胆病杂志, 2018, 34(4): 689-693.

［6］MIAO L,YANG WN, DONG XQ, et al. Combined anluohuaxianwan and entecavir treatment significantly improve the improvement rate of liver fibrosis in patients with chronic hepatitis B virus infection［J］. Chin J Hepatol， 2019, 27(7): 511-525. （in Chinese）

苗亮, 杨婉娜, 董晓琴, 等. 安络化纤丸结合恩替卡韦治疗可显著提骄气性乙型肝炎病毒传染者肝纤维化的改善率［J］. 中华肝脏病杂志, 2019, 27(7): 511-525. 

［7］GE XJ, ZHAO CQ, XU LM. Effect of Fuzheng Huayu capsules on survival rate of patients with liver cirrhosis［J］. Chin J Hepatol, 2017, 25(11): 834-890. （in Chinese）

戈雪婧， 赵长青， 徐列明. 扶正化瘀胶囊对于肝硬化患者生存率的影响［J］. 中华肝脏病杂志, 2017, 25(11): 834-890.

［8］HASSANEIN T, BOX TD, TONG MJ, et al. A phase II, randomized, placebo-controlled, double-blind, multi-center study to assess the antifibrotic activity of Fuzheng Huayu in chronic hepatitis C patients with hepatic fibrosis［J］. Gastroenterology, 2014, 146(5): s261.

［9］Shanghai Cooperative Group of Clinical Trials on Danning Tablets, FAN JG, LIU HY. A multi-centrical clinical trial of DANNING tablet for non-alcoholic fatty liver disease［J］. Int J Dig Dis, 2004, 24(2): 123-125. (in Chinese)

上海市胆宁片临床试验协作组， 范建高, 刘厚钰. 胆宁片治疗非酒精性脂肪性肝病的多中心临床试验［J］. 国际消化病杂志, 2004, 24(2): 123-125.

［10］CHEN YN, YAN JS, ZHANG YP, et al. Clinical effect of Danning tablets in treatment of nonalcoholic fatty liver disease: A meta-analysis［J］. China Health Nutrition, 2018, 28(5): 281-282. (in Chinese)

陈妍凝， 晏锦胜， 张玉佩， 等. 胆宁片治疗非酒精性脂肪肝病的Meta剖析［J］. 中国保健营养, 2018, 28(5): 281-282.

［11］LI HS, FENG Q, ZHU DD, et al. Clinical observation on qushi huayu decoction for 82 cases of non-alcoholic steatohepatitis with phlegm-stasis accumulation syndrome［J］. Chin Arch Tradit Chin Med, 2013, 31(8): 1764-1767.  (in Chinese)

李红山, 冯琴, 朱德东, 等. 祛湿化瘀方治疗痰瘀互结型非酒精性脂肪性肝炎临床视察［J］. 中华中医药学刊, 2013, 31(8): 1764-1767.

［12］PENG H, HE Y, ZHENG G, et al. Meta-analysis of traditional herbal medicine in the treatment of nonalcoholic fatty liver disease［J］. Cell Mol Biol (Noisy-le-grand), 2016, 62(4): 88-95. 

［13］LIU GB. Analysis of the curative effect of Chinese and Western medicine in the treatment of patients with chronic cholecystitis and gallstone［J］. Cardiov Dis J Integr Tradit Chin Western Med, 2016, 4(21): 193-196. (in Chinese)

刘光彬. 中西医连系治疗慢性胆囊炎胆石症患者的疗效剖析［J］. 中西医连系心血管病杂志, 2016, 4(21): 193-196.

［14］CHEN XJ, HU XQ, XU YC, et al. Effect of Dachaihu decoction on the secretion and gene expression of mucin in the gallbladder of guinea pig［J］. Jiangxi J Tradit Chin Med， 2015, 46(10): 34-36. (in Chinese)

陈小菁, 胡晓晴, 许亚超, 等. 大柴胡汤对豚鼠胆囊黏卵白排泄及其基因表达的影响［J］. 江西中医药, 2015, 46(10): 34-36.

［15］CHEN J, GUO QP. An experimental study on variant herbae artemisiae capillariae decoction for treatment of bile pigment calculus［J］. Chin Remed Clin, 2006, 6(11): 834-836． (in Chinese)

陈筠, 郭勤平. 加味茵陈蒿汤治疗胆色素结石的实验研究［J］. 中国药物与临床, 2006, 6(11): 834-836．

［16］YI YX, DING Y, ZHANG Y, et al. Yinchenhao decoction ameliorates alpha-naphthylisothiocyanate induced intrahepatic cholestasis in rats by regulating phase II metabolic enzymes and transporters［J］. Front Pharmacol, 2018, 9: 510-528.

［17］Special Committee of Digestive System Disease, Chinese Association of Integrative Medicine. Consensus statements on the integrated traditional Chinese and Western medicine diagnosis and treatment of cholelithiasis (2017)［J］. Chin J Integr Trad West Med Dig, 2018, 26(2): 132-138. (in Chinese)

中国中西医连系学会消化系统疾病专业... 胆石症中西医连系诊疗共识定见(2017年)［J］. 中国中西医连系消化杂志, 2018, 26(2):132-138.

［18］Branch of Gastrointestinal Diseases, China Association of Chinese Medicine. Expert consensus on TCM diagnosis and treatment of acute pancreatitis (2017) ［J］. J Clin Hepatol, 2017, 33(11): 2052 -2057. (in Chinese)

中华中医药学会脾胃病分会. 急性胰腺炎中医诊疗专家共识定见(2017)［J］. 临床肝胆病杂志, 2017, 33 (11): 2052 -2057.

［19］WANG JJ, CAI CC, ZHANG Q, et al. Effect of Rheum officinale combined with mirabilite on intestinal function and inflammatory factors in patients with severe acute pancreatitis［J］. Chin Tradit Patent Med, 2019, 41(5): 1191-1193. (in Chinese)

王晶晶, 蔡常春, 张晴, 等. 结合使用大黄、芒硝对重症急性胰腺炎患者肠道功能和炎症因子的影响［J］. 中成药, 2019, 41(5): 1191-1193.

［20］WANG FB, DING JT, FAN H. Effect of biliary and pancreatic duct stenting combined Danning Tablets on biliary acute recurrent pancreatitis［J］. Guangxi Med J, 2018, 40(20): 2414-2416. (in Chinese)

王富兵, 丁江涛, 范辉. 胆胰管内支架植入结合胆宁片治疗胆源性急性复发性胰腺炎的结果［J］. 广西医学, 2018, 40(20): 2414-2416.

［21］LI L, LIU J, QIN K. Meta-analysis of effectiveness of Qingyi Decoction in treatment of severe acute pancreatitis［J］. Chin J Exp Med Formul, 2015, 21(23): 207-211. (in Chinese)

李磊, 刘静, 秦侃. 清胰汤治疗重症急性胰腺炎的临床疗效的Meta剖析［J］. 中国实验方子学杂志, 2015, 21(23): 207-211.

［22］SIEGEL R, MA J, ZOU Z, et al. Cancer statistics, 2014［J］. CA Cancer J Clin, 2014, 64(1): 9-29.

［23］LU JZ, CAO XT, WANG LL. Clinical effect of traditional Chinese medicine treatment in advanced pancreatic cancer: A meta-analysis［J］.  China J Tradit Chin Med Pharma, 2014, 29(2): 441-443.  (in Chinese)

路军章, 曹秀堂, 王莉莉. 中医药治疗中晚期胰腺癌的Meta剖析［J］. 中华中医药杂志, 2014, 29(2): 441-443.

［24］LIU LM. Opportunities and challenges for integrated traditional Chinese and Western medicine therapy for pancreatic cancer［J］.  Chin J Integr Trad West Med, 2019, 39(1): 18-20.  (in Chinese)

刘鲁明. 中西医连系治疗胰腺癌的时机与挑战［J］. 中国中西医连系杂志, 2019, 39(1): 18-20.

［25］SONG LB, LIU LM, CHEN H, et al. Retrospective study of 232 post-operative patients with pancreatic cancer treated by modified qingyi huaji formula combined with western medicine［J］. Chin J Integr Trad West Med, 2018, 38(8): 932-935.  (in Chinese)

宋利斌, 刘鲁明, 陈颢, 等. 清胰化积方化裁结合西药治疗232例胰腺癌术后患者回首性研究［J］. 中国中西医连系杂志, 2018, 38(8): 932-935.